Hybrid model of erythropoiesis and leukemia treatment with cytosine arabinoside
DOI10.1137/100815517zbMATH Open1233.92034OpenAlexW1968143562WikidataQ57046937 ScholiaQ57046937MaRDI QIDQ3225271FDOQ3225271
Authors: P. Kurbatova, Samuel Bernard, N. Bessonov, Fabien Crauste, I. Demin, Charles Dumontet, Stephan Fischer, Vitaly Volpert 
Publication date: 16 March 2012
Published in: SIAM Journal on Applied Mathematics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1137/100815517
Recommendations
- Dynamics of Erythroid Progenitors and Erythroleukemia
- Hybrid models in erythropoiesis and in megakaryopoiesis
- Hybrid mathematical model of leukemic diseases
- A multi-agent model describing self-renewal of differentiation effects on the blood cell population
- A control delay differential equations model of evolution of normal and leukemic cell populations under treatment
Medical applications (general) (92C50) Probabilistic models, generic numerical methods in probability and statistics (65C20) PDEs in connection with biology, chemistry and other natural sciences (35Q92) Biological rhythms and synchronization (92B25) Cell biology (92C37) Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45)
Cited In (6)
- Blood cell dynamics: half of a century of modelling
- Discrete and continuum models for the evolutionary and spatial dynamics of cancer: a very short introduction through two case studies
- The role of spatial organization of cells in erythropoiesis
- Hybrid models in erythropoiesis and in megakaryopoiesis
- Discrete and continuum phenotype-structured models for the evolution of cancer cell populations under chemotherapy
- Mathematical models of leukaemia and its treatment: a review
This page was built for publication: Hybrid model of erythropoiesis and leukemia treatment with cytosine arabinoside
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3225271)
